Centre Extends Tenure of Rajeev Singh Raghuvanshi as DCGI Amid Ongoing Regulatory Reforms
The Centre has approved a one-year extension for Rajeev Singh Raghuvanshi as India’s top drug regulator, effective March 1, allowing…
DCGI
Read More
DCGI Launches Investigation into Alleged Illegal Clinical Trials at VS Hospital
A team from the regional office of the Drugs Controller General of India (DCGI) began an investigation into suspected unauthorized…
DCGI CUTS BLOOD BANK LICENSING TIME TO 4 MONTHS WITH DIGITAL UPGRADE
In an innovative move, the Drugs Controller General of India(DCGI) has reduced the blood bank licensing process to just four…
DCGI Firmly Confirms Bold Commitment to Drug Safety, Clarifies Misinterpretations on Spurious Labels
DCGI Clarifies Misunderstanding Over Spurious Drug Labels DCGI, in a recent statement, addressed concerns regarding the labeling of certain drugs…
DCGI Takes Bold Action on Entod Eye Drop Approval, Sparking Industry Debate as Company Vows Strong Legal Challenge
DCGI Suspends Entod Eye Drop Approval Over Misleading Claims; Company Plans to Challenge in Court DCGI, in a recent regulatory…